1.34
0.74%
-0.01
Schlusskurs vom Vortag:
$1.35
Offen:
$1.38
24-Stunden-Volumen:
127.87K
Relative Volume:
1.05
Marktkapitalisierung:
$87.50M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-126.61M
KGV:
-0.6442
EPS:
-2.08
Netto-Cashflow:
$-60.14M
1W Leistung:
-20.24%
1M Leistung:
-40.18%
6M Leistung:
-60.47%
1J Leistung:
+16.52%
Generation Bio Co Stock (GBIO) Company Profile
Firmenname
Generation Bio Co
Sektor
Branche
Telefon
857-529-5908
Adresse
301 BINNEY STREET, CAMBRIDGE
Vergleichen Sie GBIO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
GBIO | 1.34 | 87.50M | 0 | -126.61M | -60.14M | -2.08 |
VRTX | 450.60 | 115.43B | 10.63B | -479.80M | -1.35B | 13.33 |
REGN | 747.31 | 82.04B | 13.85B | 4.65B | 3.32B | 35.06 |
ARGX | 591.22 | 35.30B | 1.86B | -40.29M | -1.28B | -4.16 |
ALNY | 246.28 | 32.04B | 2.09B | -332.26M | 16.06M | -4.14 |
BNTX | 107.27 | 24.89B | 3.30B | -501.07M | 1.03B | 11.54 |
Generation Bio Co Stock (GBIO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-11-08 | Eingeleitet | Canaccord Genuity | Buy |
2021-12-14 | Herabstufung | William Blair | Outperform → Mkt Perform |
2021-06-08 | Eingeleitet | JMP Securities | Mkt Outperform |
2021-02-24 | Eingeleitet | William Blair | Outperform |
2021-02-18 | Eingeleitet | Needham | Buy |
2020-07-07 | Eingeleitet | Cowen | Outperform |
2020-07-07 | Eingeleitet | JP Morgan | Overweight |
2020-07-07 | Eingeleitet | Jefferies | Buy |
2020-07-07 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Generation Bio Co Aktie (GBIO) Neueste Nachrichten
Generation Bio Co. (GBIO) Reports Q3 Loss, Tops Revenue Estimates - MSN
SK Bioscience's SKYCellflu Recognized as Next-generation World-class Product - BusinessKorea
Generation Bio's SWOT analysis: innovative gene therapy stock faces timeline hurdles - Investing.com Australia
Delve Bio and UCSF Publish Research Demonstrating Clinical Utility of Metagenomic Next-Generation Sequencing (mNGS) for Diagnosing Serious Neurological Infections - Business Wire
Next Generation Gene pioneers gene therapy approach with China data - BioWorld Online
FY2024 EPS Estimates for Generation Bio Boosted by Analyst - MarketBeat
Earnings Update: Generation Bio Co. (NASDAQ:GBIO) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts - Yahoo Finance
Landlord’s alleged breach doesn’t justify end of rent payments - Massachusetts Lawyers Weekly
Generation Bio Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance UK
Gene Therapy Market to Grow by USD 6.74 Billion from 2024-2028, as Rise in Special Drug Designations Drives Demand with AI-Powered Market EvolutionTechnavio - The Malaysian Reserve
Generation Bio earnings beat by $0.04, revenue topped estimates - Investing.com
Generation Bio Reports Recent Business Highlights and Third Quarter 2024 Financial Results - The Manila Times
Generation Bio : Reports Recent Business Highlights and Third Quarter 2024 Financial Results Form 8 K - Marketscreener.com
Generation Bio Reports Breakthrough T-Cell Delivery, Slashes Q3 Losses by 46% | GBIO Stock News - StockTitan
Promising Penny Stocks On US Exchanges In November 2024 - Simply Wall St
Researchers Seek to Unlock the Secrets to Human Longevity - Securities.io
Bullish Generation Bio Insiders Loaded Up On US$778.9k Of Stock - Yahoo Finance
ST Launches AI-enhanced Bio-Sensing Chip for Next-gen Wearables - EE Times India
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 13.4% in October - MarketBeat
Layoff Tracker: Marinus Cuts Employees After Disappointing Phase III Trial - BioSpace
Generation Bio (NASDAQ:GBIO) Receives "Buy" Rating from Needham & Company LLC - MarketBeat
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT - The Bakersfield Californian
Generation Bio Announces the Presentation of Preclinical - GlobeNewswire
Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress - StockTitan
Cubist Systematic Strategies LLC Has $54,000 Stake in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Short Interest Down 6.1% in September - MarketBeat
Viral And Non-Viral Vector Manufacturing Market Report 2024-2033 | Size, Trends, Outlook - WhaTech
Alnylam’s founder brings in a $135M series A for City Therapeutics - BioWorld Online
City Therapeutics: $135 Million (Series A) Raised For RNAi-Based Medicine - Pulse 2.0
City Therapeutics Launches with $135 Million Series A Financing to Lead the Future of RNAi-based Medicine - BioSpace
Renaissance Technologies LLC Sells 28,100 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio's SWOT analysis: innovative dna tech propels stock potential - Investing.com India
Generation Bio Co. (NASDAQ:GBIO) Sees Large Increase in Short Interest - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Short Interest Up 13.8% in September - Defense World
Rhumbline Advisers Buys 5,430 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Bank of New York Mellon Corp Has $527,000 Position in Generation Bio Co. (NASDAQ:GBIO) - Defense World
Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration - Genetic Engineering & Biotechnology News
Comparative life cycle assessment for PBAT from fossil-derived and 2nd generation biobased feedstocks - ScienceDirect.com
GC Therapeutics Launches to Scale and Unlock the Next Generation of Cell Therapy - BioSpace
From 'science fiction to reality': New George Church-founded biotech raises $75M for cell therapy platform - Fierce Biotech
GrowGeneration Corp [GRWG] Investment Guide: What You Need to Know - Knox Daily
Gen Digital: Strong Growth, Good Fundamentals, And Decent Price Action Make A Buy - Seeking Alpha
Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion? - MarketBeat
Insider Sale Alert: Gen Digital Inc [GEN] – Is it Time to sell? - Knox Daily
Cornercap Investment Counsel Inc. Sells 16,746 Shares of Generation Bio Co. (NASDAQ:GBIO) - Defense World
Generation Bio Co. (NASDAQ:GBIO) Shares Bought by Acadian Asset Management LLC - Defense World
Choreo LLC Takes $776,000 Position in Genmab A/S (NASDAQ:GMAB) - MarketBeat
Generation Bio Co. (NASDAQ:GBIO) Shares Sold by Los Angeles Capital Management LLC - Defense World
Generation Bio to Present at the 2024 Cantor Global Healthcare Conference - ForexTV.com
Moderna falls on R&D cuts, filing delays, terminated programs - BioWorld Online
Finanzdaten der Generation Bio Co-Aktie (GBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):